Segments - Radiation Dose Optimization Software Market by Component (Software [Manual and Automatic] and Services [Education & Training and Support]), End-user (Cancer Research Institutes, Diagnostics Centers, and Hospitals), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031
The global radiation dose optimization software market size was USD XX Billion in 2022 and is likely to reach USD XX Billion by 2031, expanding at a CAGR of XX% during 2023–2031. The market growth is attributed to the rising concerns over exposure to radiation and the increasing prevalence of chronic diseases such as cancer.
Increasing usage of advanced imaging technology solutions in healthcare establishments for patient monitoring and dosage control, which is expected to propel the market. Rising prevalence of chronic diseases and preference for minimally invasive treatments are further fueling the market.
Exposure to radiation among patients has risen in the recent years with a growing preference for radiation therapy. It is highly important to monitor and control the radiation administration to eliminate the possibility of unnecessary exposure and possible side effects.
Growing reliance on medical devices and advanced healthcare software to optimize healthcare procedures is driving demand in the market. Additionally, increasing preference for advanced treatment and rising income levels are projected to boost opportunities in the market.
According to a report published by the AMERICAN SOCIETY FOR RADIATION ONCOLOGY, about two-thirds of all cancer patients are likely to receive radiation therapy. This therapy is one of three primary cancer therapies. Patients who have prostate cancer, breast cancer, and lung cancer make up half of the overall radiation therapy opting patients.
The research report finds that the COVID-19 pandemic affected the radiation dose optimization software market, as it limited the spectrum of cancer care. Factors such as an increased load of COVID-19-infected patients, shortage of facilities such as beds, equipment, medical clothing, and postponement of chemotherapies affected the market.
The demand for cancer-related technology solutions declined during the pandemic, as most of the budgetary resources and professional efforts were engaged in attending to COVID-19 patients. The fear of infection and closure/limited operations of cancer diagnostics and treatment centers declined the number of cancer patients opting for treatment during this period. All of these factors affected the market during the pandemic.
Rise in artificial intelligence is expected to have a significant impact on the market, owing to the growing preference for advanced tools and automation technologies in the healthcare sector. Growing demand for precision medicine diagnostics/therapeutics and personalized treatment for improving outcomes from the procedures, which is boosted by the use of AI-powered software and medical devices.
Some of the major benefits that AI-driven software tools can facilitate for cancer treatment are improved accuracy, better results from therapies, and support in rapid decision-making regarding medical procedures. Several cancer therapy specialist solutions with AI are emerging, which are likely to support the market growth in the coming years.
In August 2023, the National Institute for Health and Care Experience (NICE) in the UK, gave approval to nine AI technologies to accelerate contouring in radiotherapy procedure planning. In its draft guidance, the institute stated that these AI-driven technologies can be utilized for planning treatment for cancer patients undergoing external beam radiotherapy for cancer types such as lung cancer, prostate, or colorectal.
Growing concern over radiation exposure among patients is expected to be a key driver of the market. Hospitals and other healthcare establishments are focused on integrating the utmost safety tools and procedures, to eliminate every risk possibility for patients and healthcare staff.
The radiation dosage is modified based on the radiobiological response of the patient’s tumor-affected area and normal tissue during radiotherapy. These changes are monitored with the help of medical imaging, biological processes, and biochemical assays. This data is entered into radiation optimization and management tools, to optimize radiation dose distribution to the target areas.
Growing use of advanced medical imaging tools is another factor propelling the market. The software facilitates utmost care and protection from radiation to unaffected areas. This advantage is likely to boost the demand for the radiation dose optimization software market during the projection period.
According to the study by ScienceDirect in October 2023, Medical Imaging contributes 85% of the total digital healthcare venture capital funding. With the growing funding, there are several AI products are emerging, which are intended to hasten and enhance medical procedures.
The above research anticipates the count of total FDA-approved AI solutions to reach 350 in 2035 from 69 in 2022, with the growth of funding. The emergence of new AI tools is likely to transform procedures related to diagnostics radiology, with their integration into practice.
Lack of a specific benchmark for radiation dose optimization is likely to limit the market. The software cannot be completely relied on for radiation safety regulation compliance. In several cases, the limited availability of data can put significant limitations on the system’s efficiency.
These systems are required to undergo occasional auditing and updates to include observations noted by the radiologists or quality committee. These factors are expected to affect the demand in the market.
Rising demand for interventional radiology (IR) is projected to generate significant opportunities in the market. IR is a minimally invasive image-guided therapy. This procedure is carried out with imaging techniques such as X-ray fluoroscopy, magnetic resonance imaging (MRI) or ultrasound, and computer tomography.
Growing preference for advanced and minimally invasive medical procedures and their rising availability is expected to create lucrative growth prospects for the market players during the assessment period.
The global market research report includes an assessment of the market trends, market segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Radiation Dose Optimization Software Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2022 |
Historic Data |
2016–2021 |
Forecast Period |
2023–2031 |
Segmentation |
Component (Software [Manual and Automatic] and Services [Education & Training and Support]), and End-user (Cancer Research Institutes, Diagnostics Centers, and Hospitals) |
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast |
Key Players Covered in the Report |
Agfa-Gevaert Group; Bayer AG; Bracco; Fujifilm Holdings Corporation; General Electric Company; Koninklijke Philips N.V.; Medic Vision Imaging Solutions. Ltd.; QAELUM NV; Sectra AB; Siemens; and Virtual Phantoms Inc. |
Based on component, the radiation dose optimization software market is divided into software and services. The software segment is subdivided into manual and automatic. The services segment is divided into education & training and support.
The software segment is anticipated to expand at a substantial growth rate during the projection period, owing to the growing use of medical imaging technology for diagnostics and treatments and rising concerns over radiation exposure.
This software is available in two variations, automatic operating and manual. Rapid digitization is taking place in the healthcare sector, which is driven by the use of various software solutions that have specific purposes in medical applications.
The need to effectively monitor and control radiation, to ensure the safety of the patient and healthcare staff is expected to propel the segment in the coming years. Rising preference for minimally invasive surgeries (MIS) with advances in radiology is expected to increase the demand for radiation dose optimization software.
A study published in 2023 reveals that above 90% of gynecologic oncologists practice minimally invasive surgery.
The services segment is anticipated to grow at a significant pace, with an increasing preference for educating and training medical professionals about advanced digital health tools. Healthcare institutions are inclined toward digital tools that reduce the workload burden on employees and allow rapid decision-making.
Services such as consulting, education & training, and support and maintenance aid in implementing the right software tools, saving cost, and deriving efficient results from digital health solutions.
On the basis of end-user, the global market is segregated into cancer research institutes, diagnostics centers, and hospitals. The hospitals segment is projected to register a considerable CAGR during the forecast period, with the growing use of new-generation imaging technology that supports minimally invasive surgical procedures.
The preference for automatic radiation dose optimization software is high in hospitals, as it enables automatic examining, measuring, gathering, and reporting of patient radiation dose data.
At hospitals, this software facilitates real-time insights into healthcare staff’s radiation exposure for specific individuals and on a group basis. The radiation dose optimization software supports doctors in multiple procedures related to radiation exposure.
Its major use is to monitor and govern radiation dose administration in patients. The solution allows for control of several aspects of radiation dose, thereby, allowing variation of quantity as per the disease and patient’s physique.
The diagnostics centers segment is projected to expand rapidly during the assessment period, with growing footfalls at these centers for early diagnosis of chronic illnesses. Studies have proven that patients are likely to recover fast and effectively, with quick diagnosis and early stage beginning of the treatment.
Growing prevalence of chronic diseases such as cancer and cardiovascular disorders are expected to increase the implementation of radiation dose optimization software at diagnostics centers.
In terms of region, the global radiation dose optimization software market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market during the forecast period, owing to strict regulations set by various governments to direct the use of radiation in healthcare settings and a rising focus on patient safety by hospital management. Increasing preference for advanced medical procedures with growing disposable income and changing lifestyles further propel the regional market.
Rise in digitization in healthcare to improve efficiency of the diagnostics and treatments is likely to expand opportunities in the market. Furthermore, growing investments from government and private players for the development of advanced medical imaging technologies further increases the growth prospects in the market of this region.
The market in Asia Pacific is expected to exhibit rapid growth during the assessment period, with the expanding adoption of advanced healthcare technology across healthcare institutions. Growing prevalence of chronic illnesses and rising awareness about effective cure treatment are anticipated to propel the market in this region.
Increasing support from government and private institutions to the healthcare sector for the implementation of advanced medical devices and software solutions is expected to fuel opportunities in the regional market.
The global Radiation Dose Optimization Software Market has been segmented on the basis of
Key players competing in the radiation dose optimization software market are Agfa-Gevaert Group; Bayer AG; Bracco; Fujifilm Holdings Corporation; General Electric Company; Koninklijke Philips N.V.; Medic Vision Imaging Solutions. Ltd.; QAELUM NV; Sectra AB; Siemens; and Virtual Phantoms Inc.
The competitive landscape covers key insights and growth strategies such as mergers, acquisitions, partnerships, collaboration, product launches, and production expansion adopted by major market players.
On November 9, 2023, Sectra, an international medical imaging IT and cybersecurity solution company, and GE Healthcare announced working together toward seamless integration of Sectra’s enterprise imaging diagnostic application for radiology and GE HealthCare’s AW Family Advanced Visualization applications. Jointly, the two companies aim to enable smooth workflows and seamless access to next-generation, advanced visualization applications.
On May 10, 2023, Medic Vision Imaging Solutions. Ltd., a leading global provider of AI-assisted MRI solutions, inaugurated the activity of the May-Blum-Dahl Technion Human MRI Research Center (TecH MRC). It is aimed at advancing the field of MRI research.